Back to Frontier Capital Management Co. LLC Frontier Capital Management Co. LLC

KYMR

9 quarters

Position history for Frontier Capital Management Co. LLCFrontier Capital Management Co. LLC's holdings in Kymera Therapeutics, Inc.

Yes. Frontier Capital Management holds 564,133 shares of KYMR (Kymera Therapeutics), worth $63.1M, as of its Q3 2026 13F filing. It reduced the position by 176,733 shares (-23.9%) from Q2 2026. Frontier Capital Management has held KYMR since Q3 2024, across 9 quarterly 13F filings. KYMR is 0.7% of Frontier Capital Management's reported 13F portfolio.

Current Value

$63.1M

Current Shares

564,133

Total Value Change

+$44.5M

Total Shares Change

+171,870

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
564,133
-23.9%
$63.1M0.7%$111.79
0
2026-Q2
Decreased
740,866
-2.5%
$85M0.8%$114.67
0
2026-Q1
Increased
759,848
+19.5%
$63.3M0.7%$83.29
49
2025-Q4
Increased
635,957
+22.8%
$49.5M0.5%$77.81
50
2025-Q3
Increased
518,057
+5.3%
$29.3M0.3%$56.60
36
2025-Q2
Increased
491,810
+272.7%
$21.5M0.2%$43.64
55
2025-Q1
Decreased
131,963
-12.1%
$3.6M0.0%$27.37
0
2024-Q4
Decreased
150,172
-61.7%
$6M0.1%$40.23
0
2024-Q3
New
392,263
-
$18.6M0.2%$47.33
47

Other major holders of KYMR: FMR LLC, Baker Bros. Advisors LP, T. Rowe Price Associates, Inc.

Optional analytics helps us improve. How it’s used